News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
258,896 Results
Type
Article (13828)
Company Profile (293)
Press Release (244775)
Section
Business (79300)
Career Advice (148)
Deals (13176)
Drug Delivery (31)
Drug Development (50261)
Employer Resources (31)
FDA (5668)
Job Trends (5108)
News (144017)
Policy (10013)
Tag
Academia (901)
Alliances (21438)
Alzheimer's disease (729)
Approvals (5631)
Artificial intelligence (59)
Bankruptcy (97)
Best Places to Work (4457)
Biotechnology (241)
Breast cancer (56)
Cancer (568)
Cardiovascular disease (52)
Career advice (129)
CAR-T (43)
Cell therapy (147)
Clinical research (39577)
Collaboration (202)
Compensation (83)
COVID-19 (998)
C-suite (53)
Cystic fibrosis (61)
Data (612)
Diabetes (63)
Diagnostics (1190)
Earnings (28565)
Events (46466)
Executive appointments (153)
FDA (5910)
Funding (206)
Gene editing (47)
Gene therapy (126)
GLP-1 (290)
Government (1063)
Healthcare (6524)
Infectious disease (1027)
Inflammatory bowel disease (89)
IPO (7166)
Job creations (859)
Job search strategy (125)
Layoffs (181)
Legal (1372)
Lung cancer (100)
Manufacturing (66)
Medical device (2547)
Medtech (2548)
Mergers & acquisitions (6087)
Metabolic disorders (202)
Neuroscience (909)
NextGen Class of 2024 (1996)
Non-profit (841)
Northern California (779)
Obesity (117)
Opinion (90)
Parkinson's disease (55)
Patents (45)
People (24886)
Pharmaceutical (48)
Phase I (13908)
Phase II (18401)
Phase III (11681)
Pipeline (139)
Postmarket research (846)
Preclinical (5868)
Radiopharmaceuticals (203)
Rare diseases (138)
Real estate (1409)
Regulatory (8159)
Research institute (930)
Southern California (719)
Startups (1963)
United States (6532)
Vaccines (153)
Weight loss (74)
Date
Today (125)
Last 7 days (492)
Last 30 days (1762)
Last 365 days (20705)
2024 (17621)
2023 (22413)
2022 (26822)
2021 (27806)
2020 (23357)
2019 (16224)
2018 (11739)
2017 (13747)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (146)
Asia (16764)
Australia (2819)
California (1762)
Canada (643)
China (134)
Colorado (64)
Connecticut (69)
Europe (36073)
Florida (190)
Georgia (51)
Illinois (109)
Indiana (51)
Kansas (54)
Maryland (258)
Massachusetts (1459)
Michigan (45)
Minnesota (82)
New Jersey (480)
New York (538)
North Carolina (380)
Northern California (779)
Ohio (72)
Pennsylvania (373)
South America (207)
Southern California (719)
Texas (179)
Washington State (196)
258,896 Results for "akari therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholders
Akari Therapeutics Plc in follow up to the May 1st announcement that Samir R. Patel, M.D., has assumed the role of Interim President & CEO, provides detail of Dr. Patel’s employment compensation.
June 5, 2024
·
10 min read
Deals
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity
Akari Therapeutics, Plc and Peak Bio Inc. announced completion of a joint portfolio prioritization review pursuant to which the combined entity, following completion of the previously announced merger of Akari and Peak, will focus on Peak’s ADC platform technology and Akari’s PAS-nomacopan Geographic Atrophy program.
May 1, 2024
·
16 min read
Press Releases
Rob Bazemore Appointed to the Board of Directors of Akari Therapeutics
September 18, 2024
·
13 min read
Business
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
Akari Therapeutics, Plc announced leadership changes, including the appointment of experienced life sciences entrepreneur Samir R. Patel, M.D. as interim CEO.
May 1, 2024
·
16 min read
Business
Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, has reported financial results for the first quarter ended March 31, 2024 as well as recent company highlights.
May 16, 2024
·
17 min read
Business
Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
Akari Therapeutics, Plc, a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, has reported financial results for the full year 2023 as well as recent company highlights.
April 1, 2024
·
9 min read
Press Releases
Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger
October 15, 2024
·
13 min read
Genetown
Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024
Akari Therapeutics, Plc today announced the company will present new pre-clinical data on investigational long-acting PAS-nomacopan including drug effect on electroretinography (ERG) testing in a blue light model at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting in Seattle.
April 15, 2024
·
4 min read
Business
Akari Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights
August 19, 2024
·
15 min read
Deals
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
Akari Therapeutics, Plc and Peak Bio Inc. announce a definitive agreement to merge as equals in an all-stock transaction.
March 5, 2024
·
17 min read
1 of 25,890
Next
